-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I+jQR7Nb2XQBOeSU9wA36ck6qfSCh3EKqg8V8b+SFdf43set28In5ytepDB3TnN6 a/BzhUWfCWioAe30B5IiKg== 0000912057-97-004557.txt : 19970222 0000912057-97-004557.hdr.sgml : 19970222 ACCESSION NUMBER: 0000912057-97-004557 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44877 FILM NUMBER: 97526712 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY SUITE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PARKS THOMAS N CENTRAL INDEX KEY: 0000939183 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 420 STREET 2: 420 CHIPETA WAY SUITE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 8015834939 SC 13G/A 1 SC 13G/A CUSP No. 62936P-10-3 Page 1 of 5 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) NPS Pharmaceuticals, Inc. - ------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value - ------------------------------------------------------------------------------- (Title of Class of Securities 62936P-10-3 - ------------------------------------------------------------------------------- (CUSP Number) Check the following box if a fee is being paid with this statement [ ]. CUSP No. 62936P-10-3 Page 2 of 5 - -------------------------------------------------------------------------------- 1) Name of Reporting Person Thomas N. Parks S.S. or I.R.S. Identification No. of Above Person - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place of United States Organization - -------------------------------------------------------------------------------- Number of Shares 5) Sole Voting Power 344,300 shares of Common Beneficially Owned by Stock, $.001 par value Each Reporting Person ("Common Stock") With ------------------------------------------------------- 6) Shared Voting Power 0 shares of Common Stock ------------------------------------------------------------ 7) Sole Dispositive 344,300 shares of Common Power Stock ------------------------------------------------------------ 8) Shared Dispositive 0 shares of Common Power Stock ------------------------------------------------------------ 9) Aggregate Amount Beneficially 353,060 shares of Common Owned by Each Reporting Person Stock (Includes options: See Footnote 1 on page 4 of 5) - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11) Percent of Class Represented 2.99% (based on 11,807,221 by Amount in Row 9 shares outstanding as of December 31, 1996) - -------------------------------------------------------------------------------- 12) Type of Reporting Person IN - -------------------------------------------------------------------------------- CUSP No. 62936P-10-3 Page 3 of 5 SCHEDULE 13G Item 1(a). NAME OF ISSUER: NPS Pharmaceuticals, Inc. Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 420 Chipeta Way Salt Lake City, Utah 84108 Item 2(a). NAME OF PERSON FILING: Thomas N. Parks Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: University of Utah School of Medicine 416 Wintrobe Building Salt Lake City, Utah 84132 Item 2(c). CITIZENSHIP: United States Item 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $.001 par value Item 2(e). CUSP NUMBER: 62936P-10-3 Item 3. Not applicable. CUSP No. 62936P-10-3 Page 4 of 5 Item 4. OWNERSHIP. (a) Amount beneficially owned: 353,060(1) (b) Percent of class: 2.99% (based on 11,807,221 shares outstanding as of December 31, 1995) (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 344,300 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 344,300 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ]. Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. None. Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. Item 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. - ---------------- (1) Includes 8,760 shares issuable upon exercise of options within 60 days of December 31, 1996. CUSP No. 62936P-10-3 Page 5 of 5 Item 10. CERTIFICATION. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February , 1997 ---------------------------------- (Date) /s/ Thomas N. Parks ---------------------------------- (Signature) Thomas N. Parks, Director ---------------------------------- (Name and Title) -----END PRIVACY-ENHANCED MESSAGE-----